Replimune Group Inc
Ownership
Ownership Structure
Who owns Replimune Group Inc (REPL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 71.8% of the shares are freely tradable; institutional investors hold 96.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Baker Bros Advisors LP | 11.72 | 11,045,336 | +0.0 | 06/30/2026 |
| BlackRock Inc | 9.51 | 8,958,535 | +43.6 | 06/30/2026 |
| RTW INVESTMENTS, LLC | 7.87 | 7,411,581 | +0.7 | 06/30/2026 |
| Ridgeback Capital Investments L.p. | 7.76 | 7,310,656 | +0.0 | 06/30/2026 |
| The Goldman Sachs Group Inc | 4.82 | 4,541,018 | +99.4 | 06/30/2026 |
| State Street Corp | 4.71 | 4,440,144 | +17.4 | 06/30/2026 |
| Suvretta Capital Management, LLC | 4.66 | 4,389,836 | +4.0 | 06/30/2026 |
| Boxer Capital Management, LLC | 4.23 | 3,983,000 | +239.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.07 | 2,896,004 | +5.0 | 06/30/2026 |
| FCPM III SERVICES BV | 2.98 | 2,808,368 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Astley-Sparke Philip | Director | 1,362,414 | 28,201,970 $ | Aug 20, 2026 | direct |
| Patel Sushil | Chief Executive Officer | 708,151 | 14,658,726 $ | Aug 10, 2026 | direct |
| Xynos Konstantinos | Chief Medical Officer | 224,215 | 4,641,251 $ | Aug 10, 2026 | direct |
| Hill Emily Luisa | Chief Financial Officer | 215,852 | 4,468,136 $ | Aug 17, 2026 | direct |
| Schwendenman Andrew | Chief Accounting Officer | 99,425 | 2,058,098 $ | Aug 10, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Astley-Sparke Philip | Director | Other | 50,000 | 0.00 | – |
| Aug 17, 2026 | Hill Emily Luisa | Chief Financial Officer | Sell | 9,256 | 14.28 | 132,176 |
| Aug 10, 2026 | Patel Sushil | Chief Executive Officer | Sell | 39,341 | 12.97 | 510,253 |
| Aug 10, 2026 | Hill Emily Luisa | Chief Financial Officer | Sell | 11,448 | 12.97 | 148,481 |
| Aug 10, 2026 | Xynos Konstantinos | Chief Medical Officer | Sell | 11,447 | 12.97 | 148,468 |
| Aug 10, 2026 | Schwendenman Andrew | Chief Accounting Officer | Sell | 7,632 | 12.97 | 98,987 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.